0000320121-26-000012
SEC filingTelos Corporation disclosed CEO John B. Wood's medical leave and expects Q1 revenue and Adjusted EBITDA above guidance high end.
Telos Corporation announced that CEO John B. Wood is taking a medical leave of absence effective April 28, 2026, with no specified duration. In response, the Board appointed three executives—Mark Griffin, Mark Bendza, and Hutch Robbins—to assume CEO responsibilities on an interim basis, reporting to the Board. Fred Schaufeld was appointed interim Chairman. The company stated it does not anticipate material disruption to operations. Separately, Telos expects to report first-quarter revenue and Adjusted EBITDA above the high end of its guidance range provided on March 16, 2026, and will reaffirm its full-year outlook during its May 11, 2026 earnings call. The preliminary positive earnings outlook contrasts with the leadership uncertainty, but the company's proactive succession plan and reaffirmed guidance may mitigate investor concerns. The dual events—executive change and positive preliminary results—are material for investors, as leadership continuity and financial performance are critical near-term factors.